Ryokona Pharmaceuticals Private Limited
About Ryokona Pharmaceuticals Private Limited
Data last updated:
Ryokona Pharmaceuticals Private Limited is a private limited company based in Gorakhpur, Uttar Pradesh, India. It operates in the chemical products or preparations of a kind used in the textiles segment of the chemicals sector. It was incorporated on 10 August 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24297UP2016PTC085538. Its GSTIN is 09AAHCR9052M1ZP (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Ajit Singh and Bhawana.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Vill – Rajdhani Post – Rajdhani, Gorakhpur, Uttar Pradesh, India – 273202.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.59 Lakh, a decline of 34% compared to the previous year. For the same year it recorded a net profit of ₹2,878 (net margin 0.2%) and EBITDA of ₹10,867 (EBITDA margin 0.8%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 19% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ryokona Pharmaceuticals Private Limited's registered office is in Gorakhpur, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressVill – Rajdhani Post – Rajdhani, Gorakhpur, Uttar Pradesh, India – 273202
- IndustryChemicals, Chemical Products Or Preparations Of A Kind Used In The Textiles, Manufacturing, Other Chemical Product
To see the full contact details of Ryokona Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ryokona Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ryokona Pharmaceuticals Private Limited, buy the company report.
Financials of Ryokona Pharmaceuticals Private Limited
FY 2025 filings availableRyokona Pharmaceuticals Private Limited reported revenue of ₹13.59 Lakh (down 34% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 34% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 19%. EBITDA fell 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10,867 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2,878 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.8% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ryokona Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ryokona Pharmaceuticals Private Limited
Ryokona Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajit Singh | Director | 10 Aug 2016 | 10 Years 3 Months | Current |
| Bhawana | Director | 04 May 2019 | 7 Years 6 Months | Current |
Peer comparison
Ryokona Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aryan Pharmaceuticals Pvt Ltd | ₹13.69 Lakh (FY 2022) | -59.0% | Mumbai, Maharashtra, India | |||
| Dr. CSW Pharmaceuticals Private Limited | ₹13.67 Lakh (FY 2023) | 36.0% | Akola, Maharashtra, India | |||
| Ryokona Pharmaceuticals Private Limitedthis company | ₹13.59 Lakh (FY 2025) | ₹2,878 | 0.2% | -34.0% | Gorakhpur, Uttar Pradesh, India | |
| Nextone Pharmaceuticals Private Limited | ₹13.5 Lakh (FY 2024) | 65.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Ryokona Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ryokona Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ryokona Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ryokona Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAHCR9052M1ZP | Uttar Pradesh | Active | 26 Aug 2017 |
To see the full GST registrations and return filing status of Ryokona Pharmaceuticals Private Limited, buy the company report.
Recent activity
Ryokona Pharmaceuticals Private Limited has 4 board changes on record since 2016: 2 appointments and 2 cessations. The latest: Bhawana ceased to be Additional Director on 30 Dec 2020.
Frequently asked questions
Ryokona Pharmaceuticals is an active private limited company based in Gorakhpur, Uttar Pradesh, India. The company works in chemical products or preparations of a kind used in the textiles, within the chemicals industry. It was incorporated on 10 August 2016 (10+ years old) and is registered under CIN U24297UP2016PTC085538.
Ryokona Pharmaceuticals has 2 current directors:
- Ajit Singh - Director
- Bhawana - Director
The latest financial statements of Ryokona Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Ryokona Pharmaceuticals is 09AAHCR9052M1ZP, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Ryokona Pharmaceuticals is U24297UP2016PTC085538. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ryokona Pharmaceuticals was incorporated on 10 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Ryokona Pharmaceuticals by revenue are Aryan Pharmaceuticals Pvt Ltd, Dr. CSW Pharmaceuticals Private Limited, Nextone Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Bhawana ceased to be Additional Director on 30 Dec 2020. Ujjwal Kumar ceased to be Director on 06 May 2019. Bhawana was appointed as Director on 04 May 2019. Ryokona Pharmaceuticals has 4 board changes on record in total.
The registered office of Ryokona Pharmaceuticals is at Vill – Rajdhani Post – Rajdhani, Gorakhpur, Uttar Pradesh, India – 273202.
Ryokona Pharmaceuticals operates in the chemicals industry, in the chemical products or preparations of a kind used in the textiles segment.
The compliance status of Ryokona Pharmaceuticals is compliant as of 02 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
